The 10 member countries of ASEAN (the Association of Southeast Asian Nations) have agreed to collaborate more closely on the prevention, surveillance and treatment of dengue amid a steady rise in the incidence of the disease.
The 10 member countries of ASEAN (the Association of Southeast Asian Nations) have agreed to collaborate more closely on the prevention, surveillance and treatment of dengue amid a steady rise in the incidence of the disease.
The regional economic grouping issued a call to action following a regional conference and first official "Dengue Day" held in...
Deal Snapshot: Having recently raised an $89m IPO, BioVersys is partnering on and optioning rights to a preclinical NTM development program with Shionogi.
With positive relative efficacy data for its mRNA seasonal flu shot, Moderna hopes to file mRNA-1010 for US approval and refile a COVID-19/flu combo shot that it withdrew in May.
GSK tells Scrip about timelines for data expected from two Phase II trials for its Bharat Biotech-partnered shigella vaccine candidate, which puts it ahead of Limmatech/Valneva. Meanwhile, a global-first malaria vaccine, also partnered with Bharat, sees an over 50% price cut
More than a dozen vaccines for infectious diseases are in Phase III development across the industry, as the US regulatory environment brings increased uncertainty.
